The World's First Noninvasive HbA1c (Glycated Hemoglobin) Measurement 
- Diabetes Diagnosis -
The World's First Noninvasive HbA1c (Glycated Hemoglobin) Measurement 
- Diabetes Diagnosis -
QuickGly™

The world’s first non-invasive device that measures glycated hemoglobin (HbA1c) 

in real-time, essential for diabetes management. 

Unlike devices that measure blood sugar, it measures HbA1c, 

reflecting the average blood sugar level over the past three months.

QuickGly™

 

The world’s first non-invasive device that measures glycated hemoglobin (HbA1c) 

in real-time, essential for diabetes management. 

Unlike devices that measure blood sugar, it measures HbA1c, 

reflecting the average blood sugar level over the past three months.



Design Patent Application Number(Korea): 30-2024-0039134

Comprehensive Vital Sign Monitoring

It measures HbA1c, SpO2, and heart rate, with potential for glucose monitoring. Seamless integration with iOS and Android via Bluetooth allows users to monitor health data anytime, anywhere, thereby improving mobile health management.

Flexible Health Tracking with App Connectivity

 It operates independently, displaying results on the LCD, and can also be connected to iOS and Android devices via Bluetooth for continuous data monitoring and historical data tracking. This dual functionality offers users flexibility and comprehensive health insights, essential for maintaining health security.

Comprehensive Vital Sign Monitoring

It measures HbA1c, SpO2, and heart rate, with potential for glucose monitoring. Seamless integration with iOS and Android via Bluetooth allows users to monitor health data anytime, anywhere, thereby improving mobile health management. 


Flexible Health Tracking with App Connectivity

 It operates independently, displaying results on the LCD, and can also be connected to iOS and Android devices via Bluetooth for continuous data monitoring and historical data tracking. This dual functionality offers users flexibility and comprehensive health insights, essential for maintaining health security.

Accurate and Non-Invasive,
Designed 
for Everyday Use
A Reliable Diabetes Monitor, 
Always by Your Side
Our team

Introducing the Experts Driving Innovation: 

The QuickGly Team

The success of QuickGly is the result of experts from various fields coming together to achieve innovation.

Accurate and Non-Invasive,
Designed to be used Anytime, Anywhere

History

Opening the Future of Diabetes Management

The Story of QuickGly's Development

A Reliable Diabetes Monitoring, 
Always by Your Side
Pain-Free

No finger pricks

Affordable

No consumables & 3x-5x less
expensive than current options

AI-Powered

Proprietary machine learning


algorithms manage and interpret


large datasets to deliver
accurate 

blood glucose values

Our team
"Meet the Experts Behind Innovation: The QuickGly Team"

From technology development to user experience design, get to know the team that makes every step of the process possible.  


2025


▫️Launch of QuickGly™



2024


▫️Developing the World’s First Non-invasive Glycated Hemoglobin (HbA1c) Monitoring Device, QuickGly™


▫️Registered multiple patents


│08.06 

Non-invasive Biosignal Measurement Device and Method Based on Skin Effect Removal, 

US Application: 18/796,073


│01.08

System and Method for Non-invasive Measurement of Glycated Hemoglobin, 

PCT/KR2020/007958 (2020.06.19); US Application: 18/577,473


│01.08

Non-invasive Glycated Hemoglobin or Blood Glucose Measurement System and Method using Monte Carlo Simulation, PCT/KR2021/011504 (2021.08.27); US Application: 18/577,596


│01.05

Method and Apparatus for Non-invasive Estimation of Glycated Hemoglobin or Blood Glucose using 

Machine Learning, PCT/KR2022/009639 (2022.07.05); US Application: 18/405,491 (2024.01.05)



2023


▫️Patented Watch-Type Diabetes Monitoring System and filed PCT applications


▫️Led a government project - Corporate Research Institute R&D Capacity Enhancement Support Project


Project Period: 2022.04.01–2023.12.31 (Funds: $540,000)


Developed a Prototype of a Biosensor-based Glycated Hemoglobin/Blood Sugar Measurement System and Remote Care (Telemedicine) Platform


Supported by the Korea Industrial Technology Association (KOITA), funded by the Ministry of Science and ICT (MSIT), Korea


▫️Registered multiple patents


│10.25

Non-invasive Biosignal Measurement Device and Method Based on Skin Effect Removal, Reg. No: 10-2595803


│10.16

Non-invasive Biosignal Measurement Device Based on Skin Effect Removal, Reg. No: 10-2591405


│02.13

Non-invasive HbA1c and Blood Glucose Measurement Method and Device using Two Wavelengths, 

Reg. No: 10-2500415



2022


▫️Created a Care Sensor for fall prevention - Development Service



2021


▫️Developed Smart Healthcare/Home Care Solutions - Development Service



2020


▫️Attracted Investment



2019


▫️Created EDU-CODING Drone - Development Service


▫️Developed ETRI Disaster Broadcasting App Service (Government project)



2018


▫️Received Company Research Institute Approval


▫️Certified BLE beacons for corporate vehicle security (SKT) - Development Service


▫️Developed and sold Dual WiFi Beacon Plug (SKT) - Development Service


▫️Created SmartConfig Library for iPhone (SK Planet) - Development Service


▫️Developed Smart Power Socket firmware and app service (Welbas) - Development Service


▫️Developed RF Radar Software (Golf Zone) - Development Service 


    RM#920, Gangnam ACE Tower, 174-10, Jagok-ro, Gangnam-gu, Seoul, 06373, Korea

  QuickGly@KoreaIts.com 

      82-2-2421-4022

Copyright 2014 ~ Korea I.T.S Co., Ltd, All Rights Reserved.

    5F, 472, Wiryesunhwan-ro, Songpa-gu, Seoul, Republic of Korea

  QuickGly@KoreaIts.com

    82-2-421-4022


Copyright 2014 ~ Korea I.T.S Co., Ltd, All Rights Reserved.